| Pharmaceutical Information |
| Drug Name |
Midodrine |
| Drug ID |
BADD_D01461 |
| Description |
An ethanolamine derivative that is an adrenergic alpha agonist. It is used as a vasoconstrictor agent in the treatment of hypotension. |
| Indications and Usage |
For the treatment of symptomatic orthostatic hypotension (OH). |
| Marketing Status |
approved |
| ATC Code |
C01CA17 |
| DrugBank ID |
DB00211
|
| KEGG ID |
D08220
|
| MeSH ID |
D008879
|
| PubChem ID |
4195
|
| TTD Drug ID |
D02XJY
|
| NDC Product Code |
Not Available |
| UNII |
6YE7PBM15H
|
| Synonyms |
Midodrine | Midodrin | Midodrine Hydrochloride | Midodrine Monohydrochloride | Monohydrochloride, Midodrine | ProAmatine | Amatine | ST-1085 | ST 1085 | ST1085 | Gutron | Midon |
|
| Chemical Information |
| Molecular Formula |
C12H18N2O4 |
| CAS Registry Number |
42794-76-3 |
| SMILES |
COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
